GAS5 and acute myeloid leukemia: Analyzing the association of GAS5 expression level with clinical characteristic of de novo AML patients, we found that GAS5low patients had significantly higher Lactate Dehydrogenase (LDH) levels in comparison to GAS5high patients (p = 0.04).